Originally posted by marcowanger
View Post
Unconfigured Ad
Collapse
X
-
Yes, it takes so long for PLoS to reply. I sent them out last Thursday, now 6 days has passed...I think we should only wait for additional 1 to 2 days....Originally posted by genericforms View PostYes. On Friday if no one else gets back to us I will post a link and also just paste in the instructions for Genome Medicine. We can quickly refocus the article and as Joann suggested, give it a slightly medical spin. Then we can assign parts to everyone and get it done real quick.
Since I talked to the editor of GM November 23rd, we really should get something out to them soon if we end up going with their journal.
Leave a comment:
-
Robs, I have previously obtained such data. I will send it outOriginally posted by robs View PostThis would be a good point for the last part of the article. Feel free to write something about this in the wiki.
I think this will make a nice figure and some points for the discussion. Maybe we can get this data from ECO? Additionally, it would be nice to get the location data from the google analytics of this site.
Leave a comment:
-
Yes. On Friday if no one else gets back to us I will post a link and also just paste in the instructions for Genome Medicine. We can quickly refocus the article and as Joann suggested, give it a slightly medical spin. Then we can assign parts to everyone and get it done real quick.Originally posted by robs View PostFriday seems to be a good deadline for that. Could you post a link to the journal guidelines ones we have decided on one?
Since I talked to the editor of GM November 23rd, we really should get something out to them soon if we end up going with their journal.
Leave a comment:
-
Friday seems to be a good deadline for that. Could you post a link to the journal guidelines ones we have decided on one?Originally posted by genericforms View PostSo far it seems that Genome Medicine is supporting our publication and Genome Biology is not (I am not surprised). What remains to be seen is if the PLOS journals express interest. I feel if they do not, or they have not responded by this Friday, we should work from Rob's latest revisions, further define discussion points, and work towards publication in Genome Medicine.
Leave a comment:
-
This would be a good point for the last part of the article. Feel free to write something about this in the wiki.Originally posted by Joann View PostFor an additional orientation towards Genome Medicine, perhaps it would be possible to promise a future restructuring of the forum to collect and highlight such topics in a specific section.
I think this will make a nice figure and some points for the discussion. Maybe we can get this data from ECO? Additionally, it would be nice to get the location data from the google analytics of this site.Originally posted by Joann View PostFinally, I think it is important to measure the fact of a strong global participation in the forum. [...] identification of the locations of posters if this data can be harvested at some point.
Leave a comment:
-
some ideas and content
A manuscript for Plos Biology would provide an opportunity to give a short introductory perspective to next gen sequencing that most here would feel redundant perhaps--but as representatives of the field to the rest of biology this is indeed a proper task for the forum. I would suggest simply noting the technical expansion from Sanger sequencing and also mention the corresponding growth (and struggles to house) in open access sequence databases world wide.
For an additional orientation towards Genome Medicine, perhaps it would be possible to promise a future restructuring of the forum to collect and highlight such topics in a specific section. There are many important medicine informed posts here, one of the most interesting to me being a policy discussion on whole genome sequencing of He La cells for public reference, for example.
But this could also be the focus in an additional paper from the forum later on.
Finally, I think it is important to measure the fact of a strong global participation in the forum. Minimally, mention of the Wiki sequencing center map, (by means of the new Wiki citation in NAR
) but ideally some additional identification of the locations of posters if this data can be harvested at some point. It is thrilling to post along with scientists working in Bulgaria and Cyprus as well as in Boston and China.
Leave a comment:
-
Great. Let's see what they say. I am particularly interested in feedback from PLOS Biology as it is a journal with broad topics and readership.Originally posted by marcowanger View PostI just received the PloS Comp Bio manuscript ID yesterday
The PloS Biology should be in editor office for several days now.
Leave a comment:
-
I just received the PloS Comp Bio manuscript ID yesterdayOriginally posted by genericforms View PostRob, I like the headings you added.
So far it seems that Genome Medicine is supporting our publication and Genome Biology is not (I am not surprised). What remains to be seen is if the PLOS journals express interest. I feel if they do not, or they have not responded by this Friday, we should work from Rob's latest revisions, further define discussion points, and work towards publication in Genome Medicine.
The PloS Biology should be in editor office for several days now.
Leave a comment:
-
Rob, I like the headings you added.Originally posted by robs View PostI tried to put some headings for the parts of the article that I think are important. Based on this, we should assign people to the different parts to add content.
So far it seems that Genome Medicine is supporting our publication and Genome Biology is not (I am not surprised). What remains to be seen is if the PLOS journals express interest. I feel if they do not, or they have not responded by this Friday, we should work from Rob's latest revisions, further define discussion points, and work towards publication in Genome Medicine.
Leave a comment:
-
I tried to put some headings for the parts of the article that I think are important. Based on this, we should assign people to the different parts to add content.
Joann: If you have an idea for a different outline, could you please post it here or add it to the wiki?
Leave a comment:
-
outline
I think what is needed is a solid outline for the entire report since its proposed content has shifted quite significantly away from that of a brief letter (see beginning of this thread). Especially in view of incorporating a "case study" orientation as the approach to differentiating the forum from the Wiki.
Leave a comment:
-
Let's set some deadlines to make sure this gets done. I proposed picking a journal by this Friday so that we could have final focus and formatting details. I think we should also this week outline whatever changes we need to make and assign these to people.
Leave a comment:
-
I moved away the older drafts to a new linked page. It will make it clearer so prople are working on the correct draft. I also added Marco's suggestions to the meta-discussion.
I have not been so involved in the latest draft but I willing to help to expand the text to fit longer format. It is probably a good idea to split the text in different parts and let someone to take the lead.
Leave a comment:
-
++++ that is okayOriginally posted by robs View PostI think that if we have people work on different parts initially, they will be more detailed. After that, everyone should edit those.
Leave a comment:
Latest Articles
Collapse
-
by SEQadmin2
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...-
Channel: Articles
Today, 06:46 AM -
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Genome Sequencing Reveals Large, Repeat-Rich DNA in Trapdoor Spider Named for Stephen Colbert
by SEQadmin2
Started by SEQadmin2, 10-28-2026, 09:57 AM
|
0 responses
22 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:57 AM
|
||
|
Started by SEQadmin2, 10-28-2026, 09:51 AM
|
0 responses
14 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:51 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
67 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
47 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
Leave a comment: